News and Trends 20 Jul 2023
CatalYm shows importance of GDF-15 in tumor immunotherapy resistance
CatalYm has published preclinical data in Nature Communications that reveal the central role of Growth Differentiation Factor-15 (GDF-15) in the resistance of tumors to current immunotherapy. CatalYm said the findings…